Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
Pulmonary embolism - antithrombotics in all type of patients |
ACTSG (Hull) sub-group, 1992 | Tinzaparin | unfractionated heparin | | 200 (97/103) | Exploratory | | |
THESEE, 1997 | Tinzaparin | unfractionated heparin | | 608 (301/307) | Confirmatory - | | |
Campbell, 1998 | Tinzaparin | unfractionated heparin | | 16 (6/10) | | | |
Thrombosis prevention - antithrombotics in orthopedic surgery - antithrombotics in elective hip replacement - heparin (UFH or LMWH) in orthopedic surgery - LMWH in orthopedic surgery - antithrombotics in general surgery - heparin (UFH or LMWH) in general surgery - LMWH in general surgery - antithrombotics in patients with immobilization of the lower extremities |
Jorgensen, 2002 | tinzaparin | control | | 205 (99/106) | Confirmatory - | | |
Bergqvist [42] | tinzaparin | placebo | | 80 (39/41) | | | |
Lassen, 1991 | tinzaparin | placebo | hip surgery | 210 (105/105) | | | |
Leizorovicz, 1991 | tinzaparin | unfractionated heparin | abdominal surgery | 1290 (861/429) | | | |
Venous thrombosis - antithrombotics in all type of patients - LMWH in all type of patients - heparin (UFH or LMWH) in all type of patients - antithrombotics in patients with cancer |
Hull, 2006 | extended tinzaparin | standard treatment | | NA | | | |
Romera, 2009 | Tinzaparin | acenocoumarol | | 241 (119/122) | Confirmatory - | | |
Hull et al , 1992 | Tinzaparin | unfractionated heparin | | 432 (213/219) | | | |
Hull, 2002 | Tinzaparin | warfarin | | 737 (369/368) | Confirmatory - | | |